Stem cells as therapeutical option for the treatment of bronchopulmonary dysplasia
During the past decades clinical results in neonatology have improved dramatically and increased the survival rate of preterm infants significantly. However, the short and long term outcome of these high-risk preterm infants is mainly influenced by respiratory diseases and neurological damages. Desp...
Saved in:
Main Authors: | Dominik Monz (Author), Erol Tutdibi (Author), Ludwig Gortner (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2015-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
by: Yufeng Xi, et al.
Published: (2022) -
Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia
by: Sonali Chaudhury, et al.
Published: (2019) -
A Review of Placenta and Umbilical Cord-Derived Stem Cells and the Immunomodulatory Basis of Their Therapeutic Potential in Bronchopulmonary Dysplasia
by: Wai Kit Chia, et al.
Published: (2021) -
Bronchopulmonary Dysplasia: An Overview
by: Gisondo CM, et al.
Published: (2020) -
Drug Therapy for the Prevention and Treatment of Bronchopulmonary Dysplasia
by: Anjali eIyengar, et al.
Published: (2015)